G416-0054 Screening compound: 5-(2,3-dihydro-1,4-benzodioxine-6-sulfonamido)-N-[2-(3,4-dimethoxyphenyl)ethyl]pyridine-3-carboxamide

G416-0054 Screening compound: 5-(2,3-dihydro-1,4-benzodioxine-6-sulfonamido)-N-[2-(3,4-dimethoxyphenyl)ethyl]pyridine-3-carboxamide
G416-0054 Screening compound: 5-(2,3-dihydro-1,4-benzodioxine-6-sulfonamido)-N-[2-(3,4-dimethoxyphenyl)ethyl]pyridine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G416-0054
5-(2,3-dihydro-1,4-benzodioxine-6-sulfonamido)-N-[2-(3,4-dimethoxyphenyl)ethyl]pyridine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G416-0054

Molecular Formula

C24H25N3O7S (C24 H25 N3 O7 S)

Compound Name

5-(2,3-dihydro-1,4-benzodioxine-6-sulfonamido)-N-[2-(3,4-dimethoxyphenyl)ethyl]pyridine-3-carboxamide

IUPAC name

5-(23-dihydro-14-benzodioxine-6-sulfonamido)-N-[2-(34-dimethoxyphenyl)ethyl]pyridine-3-carboxamide

SMILES

COc(ccc(CCNC(c1cc(NS(c(cc2)cc3c2OCCO3)(=O)=O)cnc1)=O)c1)c1OC

InChI

InChI=1S/C24H25N3O7S/c1-31-20-5-3-16(11-22(20)32-2)7-8-26-24(28)17-12-18(15-25-14-17)27-35(29,30)19-4-6-21-23(13-19)34-10-9-33-21/h3-6,11-15,27H,7-10H2,1-2H3,(H,26,28)

InChI Key

GEVSYXYNHRCFPV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15011509

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

499.54

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.262

Distribution Coefficient, logD

1.258

Water Solubility, LogSw

-2.26

Polar Surface Area

105.834

Acid Dissociation Constant (pKa)

9.53

Base Dissociation Constant (pKb)

4.45

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

G416-0054 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G416-0054 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G416-0054?
Check Price and Availability of G416-0054, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G416-0054 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G416-0054
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G416-0054
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G416-0054 available by request